Global Injectable Viscosupplementation Market Growth 2023-2029

January 2023 | 104 pages | ID: GFB61D6927E7EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

LPI (LP Information)' newest research report, the “Injectable Viscosupplementation Industry Forecast” looks at past sales and reviews total world Injectable Viscosupplementation sales in 2022, providing a comprehensive analysis by region and market sector of projected Injectable Viscosupplementation sales for 2023 through 2029. With Injectable Viscosupplementation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Viscosupplementation industry.

This Insight Report provides a comprehensive analysis of the global Injectable Viscosupplementation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable Viscosupplementation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Injectable Viscosupplementation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Viscosupplementation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Viscosupplementation.

The global Injectable Viscosupplementation market size is projected to grow from US$ 1115.4 million in 2022 to US$ 1667.5 million in 2029; it is expected to grow at a CAGR of 1667.5 from 2023 to 2029.

The classification of Viscosupplementation Injection includes Single Injection, Three Injection, Five Injection, and the sales share of Single Injection take about 40%.

Viscosupplementation Injection is widely used in hospitals, clinics and other place. The most proportion of Viscosupplementation Injection used in Hospitals, and the proportion is 55%. North America is the largest consumption place, with a consumption market share nearly 52%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28%.

Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 63% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Viscosupplementation market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Single Injection
  • Three Injection
  • Five Injection
Segmentation by application
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Sanofi
  • Anika Therapeutics
  • Seikagaku
  • Zimmer Biomet
  • Bioventus
  • Ferring
  • LG Chem
  • Freda
  • Haohai Biological
  • Shanghai Jingfeng
Key Questions Addressed in this Report

What is the 10-year outlook for the global Injectable Viscosupplementation market?

What factors are driving Injectable Viscosupplementation market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Injectable Viscosupplementation market opportunities vary by end market size?

How does Injectable Viscosupplementation break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Injectable Viscosupplementation Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Injectable Viscosupplementation by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Injectable Viscosupplementation by Country/Region, 2018, 2022 & 2029
2.2 Injectable Viscosupplementation Segment by Type
  2.2.1 Single Injection
  2.2.2 Three Injection
  2.2.3 Five Injection
2.3 Injectable Viscosupplementation Sales by Type
  2.3.1 Global Injectable Viscosupplementation Sales Market Share by Type (2018-2023)
  2.3.2 Global Injectable Viscosupplementation Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Injectable Viscosupplementation Sale Price by Type (2018-2023)
2.4 Injectable Viscosupplementation Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Injectable Viscosupplementation Sales by Application
  2.5.1 Global Injectable Viscosupplementation Sale Market Share by Application (2018-2023)
  2.5.2 Global Injectable Viscosupplementation Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Injectable Viscosupplementation Sale Price by Application (2018-2023)

3 GLOBAL INJECTABLE VISCOSUPPLEMENTATION BY COMPANY

3.1 Global Injectable Viscosupplementation Breakdown Data by Company
  3.1.1 Global Injectable Viscosupplementation Annual Sales by Company (2018-2023)
  3.1.2 Global Injectable Viscosupplementation Sales Market Share by Company (2018-2023)
3.2 Global Injectable Viscosupplementation Annual Revenue by Company (2018-2023)
  3.2.1 Global Injectable Viscosupplementation Revenue by Company (2018-2023)
  3.2.2 Global Injectable Viscosupplementation Revenue Market Share by Company (2018-2023)
3.3 Global Injectable Viscosupplementation Sale Price by Company
3.4 Key Manufacturers Injectable Viscosupplementation Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Injectable Viscosupplementation Product Location Distribution
  3.4.2 Players Injectable Viscosupplementation Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR INJECTABLE VISCOSUPPLEMENTATION BY GEOGRAPHIC REGION

4.1 World Historic Injectable Viscosupplementation Market Size by Geographic Region (2018-2023)
  4.1.1 Global Injectable Viscosupplementation Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Injectable Viscosupplementation Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Injectable Viscosupplementation Market Size by Country/Region (2018-2023)
  4.2.1 Global Injectable Viscosupplementation Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Injectable Viscosupplementation Annual Revenue by Country/Region (2018-2023)
4.3 Americas Injectable Viscosupplementation Sales Growth
4.4 APAC Injectable Viscosupplementation Sales Growth
4.5 Europe Injectable Viscosupplementation Sales Growth
4.6 Middle East & Africa Injectable Viscosupplementation Sales Growth

5 AMERICAS

5.1 Americas Injectable Viscosupplementation Sales by Country
  5.1.1 Americas Injectable Viscosupplementation Sales by Country (2018-2023)
  5.1.2 Americas Injectable Viscosupplementation Revenue by Country (2018-2023)
5.2 Americas Injectable Viscosupplementation Sales by Type
5.3 Americas Injectable Viscosupplementation Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Injectable Viscosupplementation Sales by Region
  6.1.1 APAC Injectable Viscosupplementation Sales by Region (2018-2023)
  6.1.2 APAC Injectable Viscosupplementation Revenue by Region (2018-2023)
6.2 APAC Injectable Viscosupplementation Sales by Type
6.3 APAC Injectable Viscosupplementation Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Injectable Viscosupplementation by Country
  7.1.1 Europe Injectable Viscosupplementation Sales by Country (2018-2023)
  7.1.2 Europe Injectable Viscosupplementation Revenue by Country (2018-2023)
7.2 Europe Injectable Viscosupplementation Sales by Type
7.3 Europe Injectable Viscosupplementation Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Injectable Viscosupplementation by Country
  8.1.1 Middle East & Africa Injectable Viscosupplementation Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Injectable Viscosupplementation Revenue by Country (2018-2023)
8.2 Middle East & Africa Injectable Viscosupplementation Sales by Type
8.3 Middle East & Africa Injectable Viscosupplementation Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable Viscosupplementation
10.3 Manufacturing Process Analysis of Injectable Viscosupplementation
10.4 Industry Chain Structure of Injectable Viscosupplementation

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Injectable Viscosupplementation Distributors
11.3 Injectable Viscosupplementation Customer

12 WORLD FORECAST REVIEW FOR INJECTABLE VISCOSUPPLEMENTATION BY GEOGRAPHIC REGION

12.1 Global Injectable Viscosupplementation Market Size Forecast by Region
  12.1.1 Global Injectable Viscosupplementation Forecast by Region (2024-2029)
  12.1.2 Global Injectable Viscosupplementation Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injectable Viscosupplementation Forecast by Type
12.7 Global Injectable Viscosupplementation Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Injectable Viscosupplementation Product Portfolios and Specifications
  13.1.3 Sanofi Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 Anika Therapeutics
  13.2.1 Anika Therapeutics Company Information
  13.2.2 Anika Therapeutics Injectable Viscosupplementation Product Portfolios and Specifications
  13.2.3 Anika Therapeutics Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Anika Therapeutics Main Business Overview
  13.2.5 Anika Therapeutics Latest Developments
13.3 Seikagaku
  13.3.1 Seikagaku Company Information
  13.3.2 Seikagaku Injectable Viscosupplementation Product Portfolios and Specifications
  13.3.3 Seikagaku Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Seikagaku Main Business Overview
  13.3.5 Seikagaku Latest Developments
13.4 Zimmer Biomet
  13.4.1 Zimmer Biomet Company Information
  13.4.2 Zimmer Biomet Injectable Viscosupplementation Product Portfolios and Specifications
  13.4.3 Zimmer Biomet Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Zimmer Biomet Main Business Overview
  13.4.5 Zimmer Biomet Latest Developments
13.5 Bioventus
  13.5.1 Bioventus Company Information
  13.5.2 Bioventus Injectable Viscosupplementation Product Portfolios and Specifications
  13.5.3 Bioventus Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Bioventus Main Business Overview
  13.5.5 Bioventus Latest Developments
13.6 Ferring
  13.6.1 Ferring Company Information
  13.6.2 Ferring Injectable Viscosupplementation Product Portfolios and Specifications
  13.6.3 Ferring Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Ferring Main Business Overview
  13.6.5 Ferring Latest Developments
13.7 LG Chem
  13.7.1 LG Chem Company Information
  13.7.2 LG Chem Injectable Viscosupplementation Product Portfolios and Specifications
  13.7.3 LG Chem Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 LG Chem Main Business Overview
  13.7.5 LG Chem Latest Developments
13.8 Freda
  13.8.1 Freda Company Information
  13.8.2 Freda Injectable Viscosupplementation Product Portfolios and Specifications
  13.8.3 Freda Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Freda Main Business Overview
  13.8.5 Freda Latest Developments
13.9 Haohai Biological
  13.9.1 Haohai Biological Company Information
  13.9.2 Haohai Biological Injectable Viscosupplementation Product Portfolios and Specifications
  13.9.3 Haohai Biological Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Haohai Biological Main Business Overview
  13.9.5 Haohai Biological Latest Developments
13.10 Shanghai Jingfeng
  13.10.1 Shanghai Jingfeng Company Information
  13.10.2 Shanghai Jingfeng Injectable Viscosupplementation Product Portfolios and Specifications
  13.10.3 Shanghai Jingfeng Injectable Viscosupplementation Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Shanghai Jingfeng Main Business Overview
  13.10.5 Shanghai Jingfeng Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Injectable Viscosupplementation Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Injectable Viscosupplementation Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Injection
Table 4. Major Players of Three Injection
Table 5. Major Players of Five Injection
Table 6. Global Injectable Viscosupplementation Sales by Type (2018-2023) & (Units)
Table 7. Global Injectable Viscosupplementation Sales Market Share by Type (2018-2023)
Table 8. Global Injectable Viscosupplementation Revenue by Type (2018-2023) & ($ million)
Table 9. Global Injectable Viscosupplementation Revenue Market Share by Type (2018-2023)
Table 10. Global Injectable Viscosupplementation Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Injectable Viscosupplementation Sales by Application (2018-2023) & (Units)
Table 12. Global Injectable Viscosupplementation Sales Market Share by Application (2018-2023)
Table 13. Global Injectable Viscosupplementation Revenue by Application (2018-2023)
Table 14. Global Injectable Viscosupplementation Revenue Market Share by Application (2018-2023)
Table 15. Global Injectable Viscosupplementation Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Injectable Viscosupplementation Sales by Company (2018-2023) & (Units)
Table 17. Global Injectable Viscosupplementation Sales Market Share by Company (2018-2023)
Table 18. Global Injectable Viscosupplementation Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Injectable Viscosupplementation Revenue Market Share by Company (2018-2023)
Table 20. Global Injectable Viscosupplementation Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Injectable Viscosupplementation Producing Area Distribution and Sales Area
Table 22. Players Injectable Viscosupplementation Products Offered
Table 23. Injectable Viscosupplementation Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Injectable Viscosupplementation Sales by Geographic Region (2018-2023) & (Units)
Table 27. Global Injectable Viscosupplementation Sales Market Share Geographic Region (2018-2023)
Table 28. Global Injectable Viscosupplementation Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Injectable Viscosupplementation Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Injectable Viscosupplementation Sales by Country/Region (2018-2023) & (Units)
Table 31. Global Injectable Viscosupplementation Sales Market Share by Country/Region (2018-2023)
Table 32. Global Injectable Viscosupplementation Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Injectable Viscosupplementation Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Injectable Viscosupplementation Sales by Country (2018-2023) & (Units)
Table 35. Americas Injectable Viscosupplementation Sales Market Share by Country (2018-2023)
Table 36. Americas Injectable Viscosupplementation Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Injectable Viscosupplementation Revenue Market Share by Country (2018-2023)
Table 38. Americas Injectable Viscosupplementation Sales by Type (2018-2023) & (Units)
Table 39. Americas Injectable Viscosupplementation Sales by Application (2018-2023) & (Units)
Table 40. APAC Injectable Viscosupplementation Sales by Region (2018-2023) & (Units)
Table 41. APAC Injectable Viscosupplementation Sales Market Share by Region (2018-2023)
Table 42. APAC Injectable Viscosupplementation Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Injectable Viscosupplementation Revenue Market Share by Region (2018-2023)
Table 44. APAC Injectable Viscosupplementation Sales by Type (2018-2023) & (Units)
Table 45. APAC Injectable Viscosupplementation Sales by Application (2018-2023) & (Units)
Table 46. Europe Injectable Viscosupplementation Sales by Country (2018-2023) & (Units)
Table 47. Europe Injectable Viscosupplementation Sales Market Share by Country (2018-2023)
Table 48. Europe Injectable Viscosupplementation Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Injectable Viscosupplementation Revenue Market Share by Country (2018-2023)
Table 50. Europe Injectable Viscosupplementation Sales by Type (2018-2023) & (Units)
Table 51. Europe Injectable Viscosupplementation Sales by Application (2018-2023) & (Units)
Table 52. Middle East & Africa Injectable Viscosupplementation Sales by Country (2018-2023) & (Units)
Table 53. Middle East & Africa Injectable Viscosupplementation Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Injectable Viscosupplementation Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Injectable Viscosupplementation Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Injectable Viscosupplementation Sales by Type (2018-2023) & (Units)
Table 57. Middle East & Africa Injectable Viscosupplementation Sales by Application (2018-2023) & (Units)
Table 58. Key Market Drivers & Growth Opportunities of Injectable Viscosupplementation
Table 59. Key Market Challenges & Risks of Injectable Viscosupplementation
Table 60. Key Industry Trends of Injectable Viscosupplementation
Table 61. Injectable Viscosupplementation Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Injectable Viscosupplementation Distributors List
Table 64. Injectable Viscosupplementation Customer List
Table 65. Global Injectable Viscosupplementation Sales Forecast by Region (2024-2029) & (Units)
Table 66. Global Injectable Viscosupplementation Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Injectable Viscosupplementation Sales Forecast by Country (2024-2029) & (Units)
Table 68. Americas Injectable Viscosupplementation Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Injectable Viscosupplementation Sales Forecast by Region (2024-2029) & (Units)
Table 70. APAC Injectable Viscosupplementation Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Injectable Viscosupplementation Sales Forecast by Country (2024-2029) & (Units)
Table 72. Europe Injectable Viscosupplementation Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Injectable Viscosupplementation Sales Forecast by Country (2024-2029) & (Units)
Table 74. Middle East & Africa Injectable Viscosupplementation Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Injectable Viscosupplementation Sales Forecast by Type (2024-2029) & (Units)
Table 76. Global Injectable Viscosupplementation Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Injectable Viscosupplementation Sales Forecast by Application (2024-2029) & (Units)
Table 78. Global Injectable Viscosupplementation Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Sanofi Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Injectable Viscosupplementation Product Portfolios and Specifications
Table 81. Sanofi Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Anika Therapeutics Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 85. Anika Therapeutics Injectable Viscosupplementation Product Portfolios and Specifications
Table 86. Anika Therapeutics Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Anika Therapeutics Main Business
Table 88. Anika Therapeutics Latest Developments
Table 89. Seikagaku Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 90. Seikagaku Injectable Viscosupplementation Product Portfolios and Specifications
Table 91. Seikagaku Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Seikagaku Main Business
Table 93. Seikagaku Latest Developments
Table 94. Zimmer Biomet Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 95. Zimmer Biomet Injectable Viscosupplementation Product Portfolios and Specifications
Table 96. Zimmer Biomet Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Zimmer Biomet Main Business
Table 98. Zimmer Biomet Latest Developments
Table 99. Bioventus Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 100. Bioventus Injectable Viscosupplementation Product Portfolios and Specifications
Table 101. Bioventus Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Bioventus Main Business
Table 103. Bioventus Latest Developments
Table 104. Ferring Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 105. Ferring Injectable Viscosupplementation Product Portfolios and Specifications
Table 106. Ferring Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Ferring Main Business
Table 108. Ferring Latest Developments
Table 109. LG Chem Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 110. LG Chem Injectable Viscosupplementation Product Portfolios and Specifications
Table 111. LG Chem Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. LG Chem Main Business
Table 113. LG Chem Latest Developments
Table 114. Freda Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 115. Freda Injectable Viscosupplementation Product Portfolios and Specifications
Table 116. Freda Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Freda Main Business
Table 118. Freda Latest Developments
Table 119. Haohai Biological Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 120. Haohai Biological Injectable Viscosupplementation Product Portfolios and Specifications
Table 121. Haohai Biological Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Haohai Biological Main Business
Table 123. Haohai Biological Latest Developments
Table 124. Shanghai Jingfeng Basic Information, Injectable Viscosupplementation Manufacturing Base, Sales Area and Its Competitors
Table 125. Shanghai Jingfeng Injectable Viscosupplementation Product Portfolios and Specifications
Table 126. Shanghai Jingfeng Injectable Viscosupplementation Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Shanghai Jingfeng Main Business
Table 128. Shanghai Jingfeng Latest Developments

LIST OF FIGURES

Figure 1. Picture of Injectable Viscosupplementation
Figure 2. Injectable Viscosupplementation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable Viscosupplementation Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Injectable Viscosupplementation Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Injectable Viscosupplementation Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Injection
Figure 10. Product Picture of Three Injection
Figure 11. Product Picture of Five Injection
Figure 12. Global Injectable Viscosupplementation Sales Market Share by Type in 2022
Figure 13. Global Injectable Viscosupplementation Revenue Market Share by Type (2018-2023)
Figure 14. Injectable Viscosupplementation Consumed in Hospital
Figure 15. Global Injectable Viscosupplementation Market: Hospital (2018-2023) & (Units)
Figure 16. Injectable Viscosupplementation Consumed in Clinic
Figure 17. Global Injectable Viscosupplementation Market: Clinic (2018-2023) & (Units)
Figure 18. Injectable Viscosupplementation Consumed in Other
Figure 19. Global Injectable Viscosupplementation Market: Other (2018-2023) & (Units)
Figure 20. Global Injectable Viscosupplementation Sales Market Share by Application (2022)
Figure 21. Global Injectable Viscosupplementation Revenue Market Share by Application in 2022
Figure 22. Injectable Viscosupplementation Sales Market by Company in 2022 (Units)
Figure 23. Global Injectable Viscosupplementation Sales Market Share by Company in 2022
Figure 24. Injectable Viscosupplementation Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Injectable Viscosupplementation Revenue Market Share by Company in 2022
Figure 26. Global Injectable Viscosupplementation Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Injectable Viscosupplementation Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Injectable Viscosupplementation Sales 2018-2023 (Units)
Figure 29. Americas Injectable Viscosupplementation Revenue 2018-2023 ($ Millions)
Figure 30. APAC Injectable Viscosupplementation Sales 2018-2023 (Units)
Figure 31. APAC Injectable Viscosupplementation Revenue 2018-2023 ($ Millions)
Figure 32. Europe Injectable Viscosupplementation Sales 2018-2023 (Units)
Figure 33. Europe Injectable Viscosupplementation Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Injectable Viscosupplementation Sales 2018-2023 (Units)
Figure 35. Middle East & Africa Injectable Viscosupplementation Revenue 2018-2023 ($ Millions)
Figure 36. Americas Injectable Viscosupplementation Sales Market Share by Country in 2022
Figure 37. Americas Injectable Viscosupplementation Revenue Market Share by Country in 2022
Figure 38. Americas Injectable Viscosupplementation Sales Market Share by Type (2018-2023)
Figure 39. Americas Injectable Viscosupplementation Sales Market Share by Application (2018-2023)
Figure 40. United States Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Injectable Viscosupplementation Sales Market Share by Region in 2022
Figure 45. APAC Injectable Viscosupplementation Revenue Market Share by Regions in 2022
Figure 46. APAC Injectable Viscosupplementation Sales Market Share by Type (2018-2023)
Figure 47. APAC Injectable Viscosupplementation Sales Market Share by Application (2018-2023)
Figure 48. China Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Injectable Viscosupplementation Sales Market Share by Country in 2022
Figure 56. Europe Injectable Viscosupplementation Revenue Market Share by Country in 2022
Figure 57. Europe Injectable Viscosupplementation Sales Market Share by Type (2018-2023)
Figure 58. Europe Injectable Viscosupplementation Sales Market Share by Application (2018-2023)
Figure 59. Germany Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Injectable Viscosupplementation Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Injectable Viscosupplementation Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Injectable Viscosupplementation Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Injectable Viscosupplementation Sales Market Share by Application (2018-2023)
Figure 68. Egypt Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Injectable Viscosupplementation Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Injectable Viscosupplementation in 2022
Figure 74. Manufacturing Process Analysis of Injectable Viscosupplementation
Figure 75. Industry Chain Structure of Injectable Viscosupplementation
Figure 76. Channels of Distribution
Figure 77. Global Injectable Viscosupplementation Sales Market Forecast by Region (2024-2029)
Figure 78. Global Injectable Viscosupplementation Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Injectable Viscosupplementation Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Injectable Viscosupplementation Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Injectable Viscosupplementation Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Injectable Viscosupplementation Revenue Market Share Forecast by Application (2024-2029)


More Publications